An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents

NCT03405818 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis
Tinea Unguium

Interventions

DRUG: Tavaborole 5% Topical Solution

Sponsor

Pfizer